Announced Fri, 15 May · 16:10 IST

Statement under regulation 32(1) for the quarter ended 31.03.2026

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.9%1-day move
₹115.10
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.9-2.7-2.3-2.9-2.7-5.3-3.1+19.8
Up moveDown movePending
AI summary

Shree Hari Chemicals Export Ltd has filed a NIL statement of deviation or variation for Q4 FY26 (quarter ended March 31, 2026) under SEBI Regulation 32(1). The company raised Rs. 14,74,59,820 through multiple Preferential Issues dated November 12–13, 2024, March 5, 2025, and July 10–11, 2025. The filing confirms that the proceeds were utilized as per the originally disclosed objects with no deviations, variations, or changes in terms. No monitoring agency was applicable. The Audit Committee reviewed the statement and had no comments.

Likely market impact

No deviation from stated fund utilization is a positive compliance signal, indicating the company deployed capital as intended. No immediate impact on the stock, but consistent utilization builds investor confidence.